Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.353, 2002-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Azithromycin: cost advantage over standard penicillins for treating CAP
Inpharma, Vol. 1, Iss. 1330, 2002-01 ,pp. :
Access to resources
Recommend
Bupropion cost advantage over NRT
Inpharma, Vol. 1, Iss. 1538, 2006-01 ,pp. :
Azithromycin preferable for CAP
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 267, 2000-01 ,pp. :
Azithromycin + ceftriaxone as effective as levofloxacin for CAP
Inpharma, Vol. 1, Iss. 1473, 2005-01 ,pp. :
Generic captopril has cost advantage over valsartan after MI
Inpharma, Vol. 1, Iss. 1511, 2005-01 ,pp. :